Related references
Note: Only part of the references are listed.Myokines mediate the cross talk between skeletal muscle and other organs
Wentao Chen et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2021)
Identification of a Metabolic, Transcriptomic, and Molecular Signature of Patatin-Like Phospholipase Domain Containing 3-Mediated Acceleration of Steatohepatitis
Bubu A. Banini et al.
HEPATOLOGY (2021)
Ketohexokinase inhibition improves NASH by reducing fructose-induced steatosis and fibrogenesis
Emma L. Shepherd et al.
JHEP REPORTS (2021)
Role of gut microbiota in liver disease
Somaya A. M. Albhaisi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2020)
Redefining non-alcoholic fatty liver disease: what's in a name?
[Anonymous]
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
Update on NAFLD genetics: From new variants to the clinic
Eric Trepo et al.
JOURNAL OF HEPATOLOGY (2020)
Adipose tissue derived bacteria are associated with inflammation in obesity and type 2 diabetes
Lucas Massier et al.
GUT (2020)
Discovery of PF-06835919: A Potent Inhibitor of Ketohexokinase (KHK) for the Treatment of Metabolic Disorders Driven by the Overconsumption of Fructose
Kentaro Futatsugi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Dysregulated lipid metabolism links NAFLD to cardiovascular disease
Audrey Deprince et al.
MOLECULAR METABOLISM (2020)
PNPLA3 I148M Up-Regulates Hedgehog and Yap Signaling in Human Hepatic Stellate Cells
Francesca Virginia Bruschi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Metabolic drivers of non-alcoholic fatty liver disease
Kendra K. Bence et al.
MOLECULAR METABOLISM (2020)
Genetic and epigenetic factors determining NAFLD risk
Wenke Jonas et al.
MOLECULAR METABOLISM (2020)
Skeletal Muscle Dysfunction in the Development and Progression of Nonalcoholic Fatty Liver Disease
Sarah Altajar et al.
JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY (2020)
PNPLA3, CGI-58, and Inhibition of Hepatic Triglyceride Hydrolysis in Mice
Yang Wang et al.
HEPATOLOGY (2019)
A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease
Cyrielle Caussy et al.
NATURE COMMUNICATIONS (2019)
Role of Myokines in Regulating Skeletal Muscle Mass and Function
Jong Han Lee et al.
FRONTIERS IN PHYSIOLOGY (2019)
Role for diet in normal gut barrier function: developing guidance within the framework of food-labeling regulations
Michael Camilleri et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2019)
Accumulation of PNPLA3 on lipid droplets is the basis of associated hepatic steatosis
Soumik BasuRay et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
The role of skeletal muscle Akt in the regulation of muscle mass and glucose homeostasis
N. Jaiswal et al.
MOLECULAR METABOLISM (2019)
Non-alcoholic fatty liver disease in lean individuals
Somaya Albhaisi et al.
JHEP REPORTS (2019)
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
Naga Chalasani et al.
HEPATOLOGY (2018)
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Zobair Younossi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Link between gut-microbiome derived metabolite and shared gene-effects with hepatic steatosis and fibrosis in NAFLD
Cyrielle Caussy et al.
HEPATOLOGY (2018)
Fructose metabolism and metabolic disease
Sarah A. Hannou et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Fructose and sugar: A major mediator of non-alcoholic fatty liver disease
Thomas Jensen et al.
JOURNAL OF HEPATOLOGY (2018)
Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women
Lesley Hoyles et al.
NATURE MEDICINE (2018)
Nonalcoholic fatty liver disease is associated with dysbiosis independent of body mass index and insulin resistance
Hannah E. Da Silva et al.
SCIENTIFIC REPORTS (2018)
New insights into genetic predisposition and novel therapeutic targets for nonalcoholic fatty liver disease
Mary Barbara et al.
HEPATOBILIARY SURGERY AND NUTRITION (2018)
Gut microbiota diversity across ethnicities in the United States
Andrew W. Brooks et al.
PLOS BIOLOGY (2018)
Sarcopenia is associated with severe liver fibrosis in patients with non-alcoholic fatty liver disease
S. Petta et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Bile Acids and Nonalcoholic Fatty Liver Disease: Molecular Insights and Therapeutic Perspectives
Juan P. Arab et al.
HEPATOLOGY (2017)
Gut Microbiota Profiling of Pediatric Nonalcoholic Fatty Liver Disease and Obese Patients Unveiled by an Integrated Meta-omics-Based Approach
Federica Del Chierico et al.
HEPATOLOGY (2017)
Combined effects of the PNPLA3 rs738409, TM6SF2 rs58542926, and MBOAT7 rs641738 variants on NAFLD severity: a multicenter biopsy-based study
Marcin Krawczyk et al.
JOURNAL OF LIPID RESEARCH (2017)
The PNPLA3 I148M Variant Modulates the Fibrogenic Phenotype of Human Hepatic Stellate Cells
Francesca Virginia Bruschi et al.
HEPATOLOGY (2017)
The PNPLA3 Variant Associated With Fatty Liver Disease (I148M) Accumulates on Lipid Droplets by Evading Ubiquitylation
Soumik BasuRay et al.
HEPATOLOGY (2017)
Mutant PNPLA3 I148M Protein as Pharmacological Target for Liver Disease
Luca Valenti et al.
HEPATOLOGY (2017)
Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis
Bo Kyung Koo et al.
JOURNAL OF HEPATOLOGY (2017)
Treatment of NAFLD with diet, physical activity and exercise
Manuel Romero-Gómez et al.
JOURNAL OF HEPATOLOGY (2017)
TM6SF2 rs58542926 variant affects postprandial lipoprotein metabolism and glucose homeostasis in NAFLD
Giovanni Musso et al.
JOURNAL OF LIPID RESEARCH (2017)
Human genetic variation and the gut microbiome in disease
Andrew Brantley Hall et al.
NATURE REVIEWS GENETICS (2017)
Fructose Consumption, Lipogenesis, and Non-Alcoholic Fatty Liver Disease
Kasper W. ter Horst et al.
NUTRIENTS (2017)
Metabolism dysregulation induces a specific lipid signature of nonalcoholic steatohepatitis in patients
Franck Chiappini et al.
SCIENTIFIC REPORTS (2017)
Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease
Rohit Loomba et al.
CELL METABOLISM (2017)
Genetic and epigenetic mechanisms of NASH
Mohammed Eslam et al.
HEPATOLOGY INTERNATIONAL (2016)
The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent
Rosellina Margherita Mancina et al.
GASTROENTEROLOGY (2016)
Nonalcoholic fatty liver disease and metabolic syndrome: Shared genetic basis of pathogenesis
Silvia Sookoian et al.
HEPATOLOGY (2016)
The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe
Zobair M. Younossi et al.
HEPATOLOGY (2016)
Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
Zobair M. Younossi et al.
HEPATOLOGY (2016)
The rs2294918 E434K Variant Modulates Patatin-Like Phospholipase Domain-Containing 3 Expression and Liver Damage
Benedetta Donati et al.
HEPATOLOGY (2016)
Sarcopenia Is Associated With Significant Liver Fibrosis Independently of Obesity and Insulin Resistance in Nonalcoholic Fatty Liver Disease: Nationwide Surveys (KNHANES 2008-2011)
Yong-ho Lee et al.
HEPATOLOGY (2016)
The MBOAT7 variant rs641738 alters hepatic phosphatidylinositols and increases severity of non-alcoholic fatty liver disease in humans
Panu K. Luukkonen et al.
JOURNAL OF HEPATOLOGY (2016)
Thematic Review Series: Lipotoxicity: Many Roads to Cell Dysfunction and Cell Death The role of ER stress in lipid metabolism and lipotoxicity
Jaeseok Han et al.
JOURNAL OF LIPID RESEARCH (2016)
Thematic Review Series: Lipotoxicity: Many Roads to Cell Dysfunction and Cell Death Lipotoxic lethal and sublethal stress signaling in hepatocytes: relevance to NASH pathogenesis
Petra Hirsova et al.
JOURNAL OF LIPID RESEARCH (2016)
Endoplasmic reticulum stress related molecular mechanisms in nonalcoholic steatohepatitis
Perinur Bozaykut et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2016)
Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease
Manoela Mota et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2016)
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
Elena Buzzetti et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2016)
The effect of host genetics on the gut microbiome
Marc Jan Bonder et al.
NATURE GENETICS (2016)
The role of the gut microbiota in NAFLD
Christopher Leung et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2016)
Genetic factors that affect nonalcoholic fatty liver disease: A systematic clinical review
Tyler J. Severson et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection-Liver: The Musketeer in the Spotlight
Stefano Ballestri et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Fibrosis Progression in Nonalcoholic Fatty Liver vs Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis of Paired-Biopsy Studies
Siddharth Singh et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Mediterranean diet and non-alcoholic fatty liver disease. The need of extended and comprehensive interventions
Francesca M. Trovato et al.
CLINICAL NUTRITION (2015)
Hepatic stellate cell-expressed endosialin balances fibrogenesis and hepatocyte proliferation during liver damage
Carolin Mogler et al.
EMBO MOLECULAR MEDICINE (2015)
Transmembrane 6 Superfamily Member 2 Gene Variant Disentangles Nonalcoholic Steatohepatitis From Cardiovascular Disease
Paola Dongiovanni et al.
HEPATOLOGY (2015)
High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels
Paola Portillo-Sanchez et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Sarcopaenia is associated with NAFLD independently of obesity and insulin resistance: Nationwide surveys (KNHANES 2008-2011)
Yong-ho Lee et al.
JOURNAL OF HEPATOLOGY (2015)
The role of fatty acids in insulin resistance
Barry Sears et al.
LIPIDS IN HEALTH AND DISEASE (2015)
The Genetics of Nonalcoholic Fatty Liver Disease: Spotlight on PNPLA3 and TM6SF2
Quentin M. Anstee et al.
SEMINARS IN LIVER DISEASE (2015)
Gut microbiota and liver diseases
Masami Minemura et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Standard short-term diet ameliorates the lipid profile altered by a fructose-rich diet in rats
L. T. Cambri et al.
JOURNAL OF DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE (2015)
Pnpla3I148M Knockin Mice Accumulate PNPLA3 on Lipid Droplets and Develop Hepatic Steatosis
Eriks Smagris et al.
HEPATOLOGY (2015)
Polyunsaturated fatty acid metabolites as novel lipidomic biomarkers for noninvasive diagnosis of nonalcoholic steatohepatitis
Rohit Loomba et al.
JOURNAL OF LIPID RESEARCH (2015)
Adipogenic changes of hepatocytes in a high-fat diet-induced fatty liver mice model and non-alcoholic fatty liver disease patients
Xiaoli Pan et al.
ENDOCRINE (2015)
Genetic variants in GCKR and PNPLA3 confer susceptibility to nonalcoholic fatty liver disease in obese individuals
Yu-Cheng Lin et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2014)
Recombinant PNPLA3 protein shows triglyceride hydrolase activity and its I148M mutation results in loss of function
Piero Pingitore et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2014)
Plasma membrane phospholipase A2 controls hepatocellular fatty acid uptake and is responsive to pharmacological modulation: implications for nonalcoholic steatohepatitis
Wolfgang Stremmel et al.
FASEB JOURNAL (2014)
No Significant Effects of Ethyl-Eicosapentanoic Acid on Histologic Features of Nonalcoholic Steatohepatitis in a Phase 2 Trial
Arun J. Sanyal et al.
GASTROENTEROLOGY (2014)
Relationship Between Sarcopenia and Nonalcoholic Fatty Liver Disease: The Korean Sarcopenic Obesity Study
Ho Cheol Hong et al.
HEPATOLOGY (2014)
Systematic evaluation of coding variation identifies a candidate causal variant in TM6SF2 influencing total cholesterol and myocardial infarction risk
Oddgeir L. Holmen et al.
NATURE GENETICS (2014)
Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease
Kouichi Miura et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease
Yang-Lin Liu et al.
NATURE COMMUNICATIONS (2014)
Sarcopenia: a fate worth challenging
[Anonymous]
LANCET DIABETES & ENDOCRINOLOGY (2014)
Fatty acid transporters involved in the palmitate and oleate induced insulin resistance in primary rat hepatocytes
A. Chabowski et al.
ACTA PHYSIOLOGICA (2013)
The ERLIN1-CHUK-CWF19L1 gene cluster influences liver fat deposition and hepatic inflammation in the NHLBI Family Heart Study
Mary F. Feitosa et al.
ATHEROSCLEROSIS (2013)
Fecal Microbiome and Volatile Organic Compound Metabolome in Obese Humans With Nonalcoholic Fatty Liver Disease
Maitreyi Raman et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Genetic Predisposition in NAFLD and NASH: Impact on Severity of Liver Disease and Response to Treatment
Paola Dongiovanni et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
Intestinal Microbiota in Patients With Nonalcoholic Fatty Liver Disease
Marialena Mouzaki et al.
HEPATOLOGY (2013)
Severity of non-alcoholic steatohepatitis is associated with substitution of adipose tissue in skeletal muscle
Yoichiro Kitajima et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2013)
Toll-like receptors in alcoholic liver disease, non-alcoholic steatohepatitis and carcinogenesis
Yoon Seok Roh et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2013)
PNPLA3 I148M polymorphism and progressive liver disease
Paola Dongiovanni et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Non-alcoholic fatty liver disease (NAFLD) is associated with low level of physical activity: a population-based study
L. Gerber et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Diacylglycerol Activation of Protein Kinase Cε and Hepatic Insulin Resistance
Francois R. Jornayvaz et al.
CELL METABOLISM (2012)
Role of Obesity and Lipotoxicity in the Development of Nonalcoholic Steatohepatitis: Pathophysiology and Clinical Implications
Kenneth Cusi
GASTROENTEROLOGY (2012)
Intrahepatic Diacylglycerol Content Is Associated With Hepatic Insulin Resistance in Obese Subjects
Faidon Magkos et al.
GASTROENTEROLOGY (2012)
A Liver Full of JNK: Signaling in Regulation of Cell Function and Disease Pathogenesis, and Clinical Approaches
Ekihiro Seki et al.
GASTROENTEROLOGY (2012)
Obesity-Dependent Metabolic Signatures Associated with Nonalcoholic Fatty Liver Disease Progression
J. Barr et al.
JOURNAL OF PROTEOME RESEARCH (2012)
Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes
Andrew P. Morris et al.
NATURE GENETICS (2012)
Genetic Polymorphisms of the Human PNPLA3 Gene Are Strongly Associated with Severity of Non-Alcoholic Fatty Liver Disease in Japanese
Takahisa Kawaguchi et al.
PLOS ONE (2012)
Gut microbiome, obesity, and metabolic dysfunction
Herbert Tilg et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice
William L. Holland et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease
Naoki Kumashiro et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Human Fatty Liver Disease: Old Questions and New Insights
Jonathan C. Cohen et al.
SCIENCE (2011)
Genome-Wide Association Analysis Identifies Variants Associated with Nonalcoholic Fatty Liver Disease That Have Distinct Effects on Metabolic Traits
Elizabeth K. Speliotes et al.
PLOS GENETICS (2011)
Understanding sarcopenia as a geriatric syndrome
Alfonso J. Cruz-Jentoft et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2010)
Genetic variants regulating insulin receptor signalling are associated with the severity of liver damage in patients with non-alcoholic fatty liver disease
P. Dongiovanni et al.
GUT (2010)
Obesity and Nonalcoholic Fatty Liver Disease: Biochemical, Metabolic, and Clinical Implications
Elisa Fabbrini et al.
HEPATOLOGY (2010)
Patatin-Like Phospholipase Domain-Containing 3/Adiponutrin Deficiency in Mice Is Not Associated with Fatty Liver Disease
Weiqin Chen et al.
HEPATOLOGY (2010)
PNPLA3 Variants Specifically Confer Increased Risk for Histologic Nonalcoholic Fatty Liver Disease But Not Metabolic Disease
Elizabeth K. Speliotes et al.
HEPATOLOGY (2010)
Homozygosity for the Patatin-Like Phospholipase-3/Adiponutrin I148M Polymorphism Influences Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
Luca Valenti et al.
HEPATOLOGY (2010)
A Sequence Variation (I148M) in PNPLA3 Associated with Nonalcoholic Fatty Liver Disease Disrupts Triglyceride Hydrolysis
Shaoqing He et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Beta-globin mutations are associated with parenchymal siderosis and fibrosis in patients with non-alcoholic fatty liver disease
Luca Valenti et al.
JOURNAL OF HEPATOLOGY (2010)
Age-related changes in total and regional fat distribution
Jennifer L. Kuk et al.
AGEING RESEARCH REVIEWS (2009)
The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver
Nicola L. Beer et al.
HUMAN MOLECULAR GENETICS (2009)
A nonsynonymous gene variant in the adiponutrin gene is associated with nonalcoholic fatty liver disease severity
Silvia Sookoian et al.
JOURNAL OF LIPID RESEARCH (2009)
Metabolic flexibility and insulin resistance
Jose E. Galgani et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2008)
Definition and natural history of metabolic steatosis: clinical aspects of NAFLD, NASH and cirrhosis
L. Serfaty et al.
DIABETES & METABOLISM (2008)
The Kruppel-Like factor 6 genotype is associated with fibrosis in nonalcoholic fatty liver disease
Luca Miele et al.
GASTROENTEROLOGY (2008)
Fast-food-based hyper-alimentation can induce rapid and profound elevation of serum alanine aminotransferase in healthy subjects
S. Kechagias et al.
GUT (2008)
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Stefano Romeo et al.
NATURE GENETICS (2008)
Nonalcoholic fatty liver disease and mitochondrial dysfunction
Yongzhong Wei et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Nonalcoholic fatty liver disease and the metabolic syndrome
G Marchesini et al.
CURRENT OPINION IN LIPIDOLOGY (2005)
New hepatic fat activates PPARα to maintain glucose, lipid, and cholesterol homeostasis
MV Chakravarthy et al.
CELL METABOLISM (2005)
Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities
AJ Sanyal et al.
GASTROENTEROLOGY (2001)
Share Paper
